Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar typhimurium vaccine with regulated delayed antigen synthesis

Wei Xin, Soo Young Wanda, Yuhua Li, Shifeng Wang, Hua Mo, Roy Curtiss

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Recombinant attenuated Salmonella vaccines (RASVs) have been used extensively to express and deliver heterologous antigens to host mucosal tissues. Immune responses can be enhanced greatly when the antigen is secreted to the periplasm or extracellular compartment. The most common method for accomplishing this is by fusion of the antigen to a secretion signal sequence. Finding an optimal signal sequence is typically done empirically. To facilitate this process, we constructed a series of plasmid expression vectors, each containing a different type II signal sequence. We evaluated the utilities of these vectors by fusing two different antigens, the α-helix domains of pneumococcal surface protein A (PspA) and pneumococcal surface protein C (PspC), to the signal sequences of β-lactamase (bla SS), ompA, and phoA and the signal sequence and C-terminal peptide of β-lactamase (bla SS+CT) on Asd+ plasmids under the control of the Ptrc promoter. Strains were characterized for level of expression, subcellular antigen location, and the capacity to elicit antigen-specific immune responses and protection against challenge with Streptococcus pneumoniae in mice. The immune responses to each protein differed depending on the signal sequence used. Strains carrying the bla SS-pspA and bla SS+CT-pspC fusions yielded the largest amounts of secreted PspA and PspC, respectively, and induced the highest serum IgG titers, although all fusion proteins tested induced some level of antigen-specific IgG response. Consistent with the serum antibody responses, RASVs expressing the bla SS-pspA and bla SS+CT-pspC fusions induced the greatest protection against S. pneumoniae challenge.

Original languageEnglish (US)
Pages (from-to)3241-3254
Number of pages14
JournalInfection and Immunity
Volume76
Issue number7
DOIs
StatePublished - Jul 2008

Fingerprint

Salmonella enterica
Protein Sorting Signals
Protein C
Membrane Proteins
Vaccines
Antigens
Salmonella Vaccines
Attenuated Vaccines
Synthetic Vaccines
Streptococcus pneumoniae
Plasmids
Immunoglobulin G
Heterophile Antigens
Periplasm
Histocompatibility Antigens Class II
Serum
Antibody Formation
pneumococcal surface protein A
Serogroup
Mucous Membrane

ASJC Scopus subject areas

  • Immunology

Cite this

Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar typhimurium vaccine with regulated delayed antigen synthesis. / Xin, Wei; Wanda, Soo Young; Li, Yuhua; Wang, Shifeng; Mo, Hua; Curtiss, Roy.

In: Infection and Immunity, Vol. 76, No. 7, 07.2008, p. 3241-3254.

Research output: Contribution to journalArticle

Xin, Wei ; Wanda, Soo Young ; Li, Yuhua ; Wang, Shifeng ; Mo, Hua ; Curtiss, Roy. / Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar typhimurium vaccine with regulated delayed antigen synthesis. In: Infection and Immunity. 2008 ; Vol. 76, No. 7. pp. 3241-3254.
@article{a40acbc88d584059ae2e7f0d48cd6948,
title = "Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar typhimurium vaccine with regulated delayed antigen synthesis",
abstract = "Recombinant attenuated Salmonella vaccines (RASVs) have been used extensively to express and deliver heterologous antigens to host mucosal tissues. Immune responses can be enhanced greatly when the antigen is secreted to the periplasm or extracellular compartment. The most common method for accomplishing this is by fusion of the antigen to a secretion signal sequence. Finding an optimal signal sequence is typically done empirically. To facilitate this process, we constructed a series of plasmid expression vectors, each containing a different type II signal sequence. We evaluated the utilities of these vectors by fusing two different antigens, the α-helix domains of pneumococcal surface protein A (PspA) and pneumococcal surface protein C (PspC), to the signal sequences of β-lactamase (bla SS), ompA, and phoA and the signal sequence and C-terminal peptide of β-lactamase (bla SS+CT) on Asd+ plasmids under the control of the Ptrc promoter. Strains were characterized for level of expression, subcellular antigen location, and the capacity to elicit antigen-specific immune responses and protection against challenge with Streptococcus pneumoniae in mice. The immune responses to each protein differed depending on the signal sequence used. Strains carrying the bla SS-pspA and bla SS+CT-pspC fusions yielded the largest amounts of secreted PspA and PspC, respectively, and induced the highest serum IgG titers, although all fusion proteins tested induced some level of antigen-specific IgG response. Consistent with the serum antibody responses, RASVs expressing the bla SS-pspA and bla SS+CT-pspC fusions induced the greatest protection against S. pneumoniae challenge.",
author = "Wei Xin and Wanda, {Soo Young} and Yuhua Li and Shifeng Wang and Hua Mo and Roy Curtiss",
year = "2008",
month = "7",
doi = "10.1128/IAI.01623-07",
language = "English (US)",
volume = "76",
pages = "3241--3254",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "7",

}

TY - JOUR

T1 - Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar typhimurium vaccine with regulated delayed antigen synthesis

AU - Xin, Wei

AU - Wanda, Soo Young

AU - Li, Yuhua

AU - Wang, Shifeng

AU - Mo, Hua

AU - Curtiss, Roy

PY - 2008/7

Y1 - 2008/7

N2 - Recombinant attenuated Salmonella vaccines (RASVs) have been used extensively to express and deliver heterologous antigens to host mucosal tissues. Immune responses can be enhanced greatly when the antigen is secreted to the periplasm or extracellular compartment. The most common method for accomplishing this is by fusion of the antigen to a secretion signal sequence. Finding an optimal signal sequence is typically done empirically. To facilitate this process, we constructed a series of plasmid expression vectors, each containing a different type II signal sequence. We evaluated the utilities of these vectors by fusing two different antigens, the α-helix domains of pneumococcal surface protein A (PspA) and pneumococcal surface protein C (PspC), to the signal sequences of β-lactamase (bla SS), ompA, and phoA and the signal sequence and C-terminal peptide of β-lactamase (bla SS+CT) on Asd+ plasmids under the control of the Ptrc promoter. Strains were characterized for level of expression, subcellular antigen location, and the capacity to elicit antigen-specific immune responses and protection against challenge with Streptococcus pneumoniae in mice. The immune responses to each protein differed depending on the signal sequence used. Strains carrying the bla SS-pspA and bla SS+CT-pspC fusions yielded the largest amounts of secreted PspA and PspC, respectively, and induced the highest serum IgG titers, although all fusion proteins tested induced some level of antigen-specific IgG response. Consistent with the serum antibody responses, RASVs expressing the bla SS-pspA and bla SS+CT-pspC fusions induced the greatest protection against S. pneumoniae challenge.

AB - Recombinant attenuated Salmonella vaccines (RASVs) have been used extensively to express and deliver heterologous antigens to host mucosal tissues. Immune responses can be enhanced greatly when the antigen is secreted to the periplasm or extracellular compartment. The most common method for accomplishing this is by fusion of the antigen to a secretion signal sequence. Finding an optimal signal sequence is typically done empirically. To facilitate this process, we constructed a series of plasmid expression vectors, each containing a different type II signal sequence. We evaluated the utilities of these vectors by fusing two different antigens, the α-helix domains of pneumococcal surface protein A (PspA) and pneumococcal surface protein C (PspC), to the signal sequences of β-lactamase (bla SS), ompA, and phoA and the signal sequence and C-terminal peptide of β-lactamase (bla SS+CT) on Asd+ plasmids under the control of the Ptrc promoter. Strains were characterized for level of expression, subcellular antigen location, and the capacity to elicit antigen-specific immune responses and protection against challenge with Streptococcus pneumoniae in mice. The immune responses to each protein differed depending on the signal sequence used. Strains carrying the bla SS-pspA and bla SS+CT-pspC fusions yielded the largest amounts of secreted PspA and PspC, respectively, and induced the highest serum IgG titers, although all fusion proteins tested induced some level of antigen-specific IgG response. Consistent with the serum antibody responses, RASVs expressing the bla SS-pspA and bla SS+CT-pspC fusions induced the greatest protection against S. pneumoniae challenge.

UR - http://www.scopus.com/inward/record.url?scp=46449130050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46449130050&partnerID=8YFLogxK

U2 - 10.1128/IAI.01623-07

DO - 10.1128/IAI.01623-07

M3 - Article

VL - 76

SP - 3241

EP - 3254

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 7

ER -